A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease
Study sponsor: Palatin Technologies, Inc · PTN
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2024-04-26Actual
Enrollment · participants16Actual
Source updated2024-10-17Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.